DECEMBER - 20206December - 22 - 2020, volume 04 - Issue 29 (ISSN 2691-4093) Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerJohn GothamSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.comEmailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comThe alarming rate at which neurological disorders are rising is a cause of concern globally. These disorders increase the risk of unfavorable health outcomes, including but not limited to mortality, physical disability, strokes, dementia, and Parkinson's disease. To challenge the prevalence of such diseases, there arose a need to adopt neuromodulation techniques.The electrical neuromodulation therapy has FDA approval for treating a majority of neurological diseases, such as bladder control, tremors, chronic pain, and spinal cord injury, commonly found in the aging population. Spinal cord stimulation (SCS), deep brain stimulation, vagus nerve stimulation (VNS), and sacral nerve stimulation (SNS) techniques and devices are among the most preferred treatment procedures in use for neurological ailments. SCS is specially used to treat chronic backache, while VNS is suitable for conditions such as epilepsy.New targets, like the dorsal root ganglion, along with stimulation methodologies such as burst stimulation, are leading the way to efficient and better clinical results. In the coming future, neural sensing, stimulation patterns, and techniques combining neuromodulation treatment will significantly impact the way neuromodulation is used. Additionally, certain biomarkers may influence the use of neuromodulation, thus leading to desired outcomes.Apart from therapies utilizing electricity, optogenetics has ensured that pain can be inhibited as per the targeted cells. Though in the initial stage, the approach of using light to specifically inhibit or activate neurons provides a powerful tool to control neural functions.These new techniques, coupled with innovative neuromodulation devices, are gathering speed. Highlighting these new developments in the medical devices landscape, this edition of MedTech Outlook features a list of the vendors at the top in their game, coupled with insightful articles from various thought leaders. We hope the valuable information and cutting-edge solutions from leading companies will help you make an informed choice for your endeavors in the neuromodulation devices arena.Let us know your thoughts!Neuromodulation Elevating Medical EfficacySarah FernandesEDITORIAL
< Page 5 | Page 7 >